Cargando…

Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: Relation to the immune cycle

BACKGROUND: Various histological types of gastric carcinomas (GCs) differ in terms of their pathogenesis and their preexisting background, both of which could impact the tumor immune microenvironment (TIME). However, the current understanding of the immune contexture of GC is far from complete. AIM:...

Descripción completa

Detalles Bibliográficos
Autores principales: Mashukov, Artem, Shapochka, Dmytro, Seleznov, Oleksii, Kobyliak, Nazarii, Falalyeyeva, Tetyana, Kirkilevsky, Stanislav, Yarema, Roman, Sulaieva, Oksana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384749/
https://www.ncbi.nlm.nih.gov/pubmed/34497449
http://dx.doi.org/10.3748/wjg.v27.i31.5259
_version_ 1783741959778598912
author Mashukov, Artem
Shapochka, Dmytro
Seleznov, Oleksii
Kobyliak, Nazarii
Falalyeyeva, Tetyana
Kirkilevsky, Stanislav
Yarema, Roman
Sulaieva, Oksana
author_facet Mashukov, Artem
Shapochka, Dmytro
Seleznov, Oleksii
Kobyliak, Nazarii
Falalyeyeva, Tetyana
Kirkilevsky, Stanislav
Yarema, Roman
Sulaieva, Oksana
author_sort Mashukov, Artem
collection PubMed
description BACKGROUND: Various histological types of gastric carcinomas (GCs) differ in terms of their pathogenesis and their preexisting background, both of which could impact the tumor immune microenvironment (TIME). However, the current understanding of the immune contexture of GC is far from complete. AIM: To clarify the tumor-host immune interplay through histopathological features and the tumor immune cycle concept. METHODS: In total, 50 GC cases were examined (15 cases of diffuse GC, 31 patients with intestinal-type GC and 4 cases of mucinous GC). The immunophenotype of GC was assessed and classified as immune desert (ID), immune excluded (IE) or inflamed (Inf) according to CD8+ cell count and spatial pattern. In addition, CD68+ and CD163+ macrophages and programmed death-ligand 1 (PD-L1) expression were estimated. RESULTS: We found that GCs with different histological differentiation demonstrated distinct immune contexture. Most intestinal-type GCs had inflamed TIMEs rich in both CD8+ cells and macrophages. In contrast, more aggressive diffuse-type GC more often possessed ID characteristics with few CD8+ lymphocytes but abundant CD68+ macrophages, while mucinous GC had an IE-TIME with a prevalence of CD68+ macrophages and CD8+ lymphocytes in the peritumor stroma. PD-L1 expression prevailed mostly in intestinal-type Inf-GC, with numerous CD163+ cells observed. Therefore, GCs of different histological patterns have specific mechanisms of immune escape. While intestinal-type GC was more often related to PD-L1 expression, diffuse and mucinous GCs possessing more aggressive behavior demonstrated low immunogenicity and a lack of tumor antigen recognition or immune cell recruitment into the tumor clusters. CONCLUSION: These data help to clarify the links between tumor histogenesis and immunogenicity for a better understanding of GC biology and more tailored patient management.
format Online
Article
Text
id pubmed-8384749
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-83847492021-09-07 Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: Relation to the immune cycle Mashukov, Artem Shapochka, Dmytro Seleznov, Oleksii Kobyliak, Nazarii Falalyeyeva, Tetyana Kirkilevsky, Stanislav Yarema, Roman Sulaieva, Oksana World J Gastroenterol Retrospective Study BACKGROUND: Various histological types of gastric carcinomas (GCs) differ in terms of their pathogenesis and their preexisting background, both of which could impact the tumor immune microenvironment (TIME). However, the current understanding of the immune contexture of GC is far from complete. AIM: To clarify the tumor-host immune interplay through histopathological features and the tumor immune cycle concept. METHODS: In total, 50 GC cases were examined (15 cases of diffuse GC, 31 patients with intestinal-type GC and 4 cases of mucinous GC). The immunophenotype of GC was assessed and classified as immune desert (ID), immune excluded (IE) or inflamed (Inf) according to CD8+ cell count and spatial pattern. In addition, CD68+ and CD163+ macrophages and programmed death-ligand 1 (PD-L1) expression were estimated. RESULTS: We found that GCs with different histological differentiation demonstrated distinct immune contexture. Most intestinal-type GCs had inflamed TIMEs rich in both CD8+ cells and macrophages. In contrast, more aggressive diffuse-type GC more often possessed ID characteristics with few CD8+ lymphocytes but abundant CD68+ macrophages, while mucinous GC had an IE-TIME with a prevalence of CD68+ macrophages and CD8+ lymphocytes in the peritumor stroma. PD-L1 expression prevailed mostly in intestinal-type Inf-GC, with numerous CD163+ cells observed. Therefore, GCs of different histological patterns have specific mechanisms of immune escape. While intestinal-type GC was more often related to PD-L1 expression, diffuse and mucinous GCs possessing more aggressive behavior demonstrated low immunogenicity and a lack of tumor antigen recognition or immune cell recruitment into the tumor clusters. CONCLUSION: These data help to clarify the links between tumor histogenesis and immunogenicity for a better understanding of GC biology and more tailored patient management. Baishideng Publishing Group Inc 2021-08-21 2021-08-21 /pmc/articles/PMC8384749/ /pubmed/34497449 http://dx.doi.org/10.3748/wjg.v27.i31.5259 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Retrospective Study
Mashukov, Artem
Shapochka, Dmytro
Seleznov, Oleksii
Kobyliak, Nazarii
Falalyeyeva, Tetyana
Kirkilevsky, Stanislav
Yarema, Roman
Sulaieva, Oksana
Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: Relation to the immune cycle
title Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: Relation to the immune cycle
title_full Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: Relation to the immune cycle
title_fullStr Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: Relation to the immune cycle
title_full_unstemmed Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: Relation to the immune cycle
title_short Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: Relation to the immune cycle
title_sort histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: relation to the immune cycle
topic Retrospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384749/
https://www.ncbi.nlm.nih.gov/pubmed/34497449
http://dx.doi.org/10.3748/wjg.v27.i31.5259
work_keys_str_mv AT mashukovartem histologicaldifferentiationimpactsthetumorimmunemicroenvironmentingastriccarcinomarelationtotheimmunecycle
AT shapochkadmytro histologicaldifferentiationimpactsthetumorimmunemicroenvironmentingastriccarcinomarelationtotheimmunecycle
AT seleznovoleksii histologicaldifferentiationimpactsthetumorimmunemicroenvironmentingastriccarcinomarelationtotheimmunecycle
AT kobyliaknazarii histologicaldifferentiationimpactsthetumorimmunemicroenvironmentingastriccarcinomarelationtotheimmunecycle
AT falalyeyevatetyana histologicaldifferentiationimpactsthetumorimmunemicroenvironmentingastriccarcinomarelationtotheimmunecycle
AT kirkilevskystanislav histologicaldifferentiationimpactsthetumorimmunemicroenvironmentingastriccarcinomarelationtotheimmunecycle
AT yaremaroman histologicaldifferentiationimpactsthetumorimmunemicroenvironmentingastriccarcinomarelationtotheimmunecycle
AT sulaievaoksana histologicaldifferentiationimpactsthetumorimmunemicroenvironmentingastriccarcinomarelationtotheimmunecycle